Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

New Year so far for Intuitive Surgical (NASDAQ: ISRG) shareholders. The robotic surgical systems stock is in negative ...

I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth ...

The bullish case for the stock remains strong.

SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...

Intuitive Surgical's stock is poised to return over 60% in 2024, driven by strong tailwinds in the MedTech industry and elevated capital investments. The da Vinci 5 system has been well received, with ...